APA (7th ed.) Citation

Walicka-Serzysko, K., Postek, M., Mielus, M., Borawska-Kowalczyk, U., Milczewska, J., Zybert, K., . . . Sands, D. (2025). Comprehensive Evaluation of Elexacaftor/Tezacaftor/Ivacaftor in Paediatric Cystic Fibrosis: Nutritional, Pulmonary, and Quality-of-Life Outcomes †. Journal of Clinical Medicine, 14(22), 7969. https://doi.org/10.3390/jcm14227969

Chicago Style (17th ed.) Citation

Walicka-Serzysko, Katarzyna, Magdalena Postek, Monika Mielus, Urszula Borawska-Kowalczyk, Justyna Milczewska, Katarzyna Zybert, Łukasz Wozniacki, Anna Wołkowicz, and Dorota Sands. "Comprehensive Evaluation of Elexacaftor/Tezacaftor/Ivacaftor in Paediatric Cystic Fibrosis: Nutritional, Pulmonary, and Quality-of-Life Outcomes †." Journal of Clinical Medicine 14, no. 22 (2025): 7969. https://doi.org/10.3390/jcm14227969.

MLA (9th ed.) Citation

Walicka-Serzysko, Katarzyna, et al. "Comprehensive Evaluation of Elexacaftor/Tezacaftor/Ivacaftor in Paediatric Cystic Fibrosis: Nutritional, Pulmonary, and Quality-of-Life Outcomes †." Journal of Clinical Medicine, vol. 14, no. 22, 2025, p. 7969, https://doi.org/10.3390/jcm14227969.